449 related articles for article (PubMed ID: 23887844)
1. Predicting clinical outcomes after thrombolysis using the iScore: results from the Virtual International Stroke Trials Archive.
Saposnik G; Reeves MJ; Johnston SC; Bath PM; Ovbiagele B;
Stroke; 2013 Oct; 44(10):2755-9. PubMed ID: 23887844
[TBL] [Abstract][Full Text] [Related]
2. The iScore predicts efficacy and risk of bleeding in the National Institute of Neurological disorders and Stroke Tissue Plasminogen Activator Stroke Trial.
Saposnik G; Demchuk A; Tu JV; Johnston SC;
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):876-82. PubMed ID: 23102741
[TBL] [Abstract][Full Text] [Related]
3. The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke.
Saposnik G; Fang J; Kapral MK; Tu JV; Mamdani M; Austin P; Johnston SC; ;
Stroke; 2012 May; 43(5):1315-22. PubMed ID: 22308252
[TBL] [Abstract][Full Text] [Related]
4. The iScore predicts clinical response to tissue plasminogen activator in Korean stroke patients.
Park TH; Park SS; Ko Y; Lee SJ; Lee KB; Lee J; Kang K; Park JM; Choi JC; Kim DE; Cho YJ; Hong KS; Kim JT; Kim DH; Cha JK; Han MK; Lee JS; Lee J; Yu KH; Lee BC; Yoon BW; Bae HJ; Saposnik G
J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):367-73. PubMed ID: 23800501
[TBL] [Abstract][Full Text] [Related]
5. THRIVE score predicts ischemic stroke outcomes and thrombolytic hemorrhage risk in VISTA.
Flint AC; Faigeles BS; Cullen SP; Kamel H; Rao VA; Gupta R; Smith WS; Bath PM; Donnan GA;
Stroke; 2013 Dec; 44(12):3365-9. PubMed ID: 24072004
[TBL] [Abstract][Full Text] [Related]
6. Revised iScore to predict outcomes after acute ischemic stroke.
Sung SF; Chen YW; Hung LC; Lin HJ
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1634-9. PubMed ID: 24709145
[TBL] [Abstract][Full Text] [Related]
7. Response to letter regarding article, "Predicting clinical outcomes after thrombolysis using the iScore: results from the Virtual International Stroke Trials Archive".
Saposnik G; Johnston SC; Ovbiagele B;
Stroke; 2013 Nov; 44(11):e155. PubMed ID: 24085024
[No Abstract] [Full Text] [Related]
8. Letter by Rangaraju and Jadhav regarding article, "Predicting clinical outcomes after thrombolysis using the iScore: results from the Virtual International Stroke Trials Archive".
Rangaraju S; Jadhav AP
Stroke; 2013 Nov; 44(11):e154. PubMed ID: 24085022
[No Abstract] [Full Text] [Related]
9. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
Kruetzelmann A; Köhrmann M; Sobesky J; Cheng B; Rosenkranz M; Röther J; Schellinger PD; Ringleb P; Gerloff C; Fiehler J; Thomalla G
Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399
[TBL] [Abstract][Full Text] [Related]
10. Atrial fibrillation in ischemic stroke: predicting response to thrombolysis and clinical outcomes.
Saposnik G; Gladstone D; Raptis R; Zhou L; Hart RG;
Stroke; 2013 Jan; 44(1):99-104. PubMed ID: 23168456
[TBL] [Abstract][Full Text] [Related]
11. The totaled health risks in vascular events (THRIVE) score predicts ischemic stroke outcomes independent of thrombolytic therapy in the NINDS tPA trial.
Kamel H; Patel N; Rao VA; Cullen SP; Faigeles BS; Smith WS; Flint AC
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1111-6. PubMed ID: 23122722
[TBL] [Abstract][Full Text] [Related]
12. Influence of age on outcome from thrombolysis in acute stroke: a controlled comparison in patients from the Virtual International Stroke Trials Archive (VISTA).
Mishra NK; Diener HC; Lyden PD; Bluhmki E; Lees KR;
Stroke; 2010 Dec; 41(12):2840-8. PubMed ID: 21030710
[TBL] [Abstract][Full Text] [Related]
13. A simple risk index and thrombolytic treatment response in acute ischemic stroke.
Ovbiagele B; Reeves MJ; Nasiri M; Johnston SC; Bath PM; Saposnik G;
JAMA Neurol; 2014 Jul; 71(7):848-54. PubMed ID: 24798141
[TBL] [Abstract][Full Text] [Related]
14. Predicting clinical outcomes and response to thrombolysis in acute stroke patients with diabetes.
Nikneshan D; Raptis R; Pongmoragot J; Zhou L; Johnston SC; Saposnik G; ;
Diabetes Care; 2013 Jul; 36(7):2041-7. PubMed ID: 23359359
[TBL] [Abstract][Full Text] [Related]
15. Added Benefit of Stent Retriever Technology for Acute Ischemic Stroke: A Pooled Analysis of the NINDS tPA, SWIFT, and STAR Trials.
Saposnik G; Lebovic G; Demchuk A; Levy EI; Ovbiagele B; Goyal M; Johnston SC;
Neurosurgery; 2015 Sep; 77(3):454-61. PubMed ID: 26280825
[TBL] [Abstract][Full Text] [Related]
16. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
[TBL] [Abstract][Full Text] [Related]
17. Initial body temperature in ischemic stroke: nonpotentiation of tissue-type plasminogen activator benefit and inverse association with severity.
Kim SH; Saver JL
Stroke; 2015 Jan; 46(1):132-6. PubMed ID: 25424482
[TBL] [Abstract][Full Text] [Related]
18. Thrombolysis is associated with consistent functional improvement across baseline stroke severity: a comparison of outcomes in patients from the Virtual International Stroke Trials Archive (VISTA).
Mishra NK; Lyden P; Grotta JC; Lees KR;
Stroke; 2010 Nov; 41(11):2612-7. PubMed ID: 20947852
[TBL] [Abstract][Full Text] [Related]
19. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
[TBL] [Abstract][Full Text] [Related]
20. Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis.
Carr SJ; Wang X; Olavarria VV; Lavados PM; Rodriguez JA; Kim JS; Lee TH; Lindley RI; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Woodward M; Chalmers J; Anderson CS; Robinson TG;
Stroke; 2017 Sep; 48(9):2605-2609. PubMed ID: 28739832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]